Dr. Mehmet Oz, the celebrity TV doctor-turned-federal-administrator, publicly broke with his boss, Donald Trump, on Tuesday after the president made wild claims about Tylenol being a cause of autism ...

Dr. Mehmet Oz is President-elect Donald Trump's pick to run the Centers for Medicare and Medicaid Services. Announcing the ...

The Centers for Medicare and Medicaid Services (CMS) administrator Dr. Mehmet Oz has clarified what the federal guidance is on when it's safe for pregnant women to take the commonly used pain and ...

Dr Oz explains 'main emphasis' on Trump admin's warning about rising autism rates CMS Administrator Dr. Mehmet Oz responds to Tylenol rejecting the Trump administration's autism claims and touts an ...

Would Dr. Mehmet Oz, a former diet supplement company advisor and investor, profit from the Trump Administration's plan to recommend folinic acid for those on the autism spectrum? No, that's not true: ...

CNN’s Jake Tapper pressed Dr. Mehmet Oz Friday when the cardiologist and former T.V. doctor asserted that autism is a modern phenomenon. Dr. Oz serves as the administrator for the Centers for Medicare ...

Dr Oz warns against what sometimes 'destroys families' CMS administrator Dr. Mehmet Oz and FDA Commissioner Dr. Marty Makary defend the Trump administration's claim that Tylenol i ...

Dr. Mehmet Oz softened President Trump's warnings that pregnant women should not take Tylenol due to a largely unproven link to autism. In an interview with TMZ, Oz, who leads CMS, said pregnant women ...

Dr. Mehmet Oz told CBS News chief Washington correspondent Major Garrett on "The Takeout" Thursday the Trump administration is not advising pregnant women to avoid taking Tylenol under any ...

In a move that signals significant changes for America’s healthcare landscape, President-elect Donald Trump announced Tuesday his intent to nominate Dr. Mehmet Oz to lead the Centers for Medicare and ...

CBRE is marketing a compact Auckland CBD accommodation tower at a rarely-available price point, creating an accessible entry opportunity into a high-demand sector with strong potential to add value.

Dr Oetker’s UK arm has improved its profits despite investing in keeping prices low, according to the latest accounts filed at Companies House. Operating profit at Dr Oetker rose 36% to £36.5m as ...